Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$513.7K
0M shares
52-week range
$1.25 – $235.20
0% from low
Sector
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Exchange
NASDAQ
CS
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
www.nuwellis.comNo one on the platform currently holds NUWE.
No tracked institution reports a position in NUWE as of their last filing.
| Execution date | Ratio |
|---|---|
| 2026-06-26 | 1-for-35reverse |
| 2025-07-07 | 1-for-42reverse |
| 2024-06-28 | 1-for-35reverse |
| 2022-12-12 | 1-for-100reverse |
| 2020-10-19 | 1-for-30reverse |
No one on the platform has traded NUWE yet.
$NUWE consolidating.. maybe a move soon 🐺
View on StockTwits ↗$NUWE Even though I loaded it yesterday at 1.28 I hope it does not see another short squeeze in the next few days so it would give me more time to add more . I think Nuwe at this price must be my favorite stock to put money for a short squeeze play.
View on StockTwits ↗$NUWE this stock has 52 percent short float. I don’t get it. Where’s the squeeeeeze.
View on StockTwits ↗$NUWE Closed position with small gain. Was hoping for AH gap. GLTA
View on StockTwits ↗$NUWE issued its Q2 and six-month 2026 results via a press release on August 13. https://www.rapidticker.com/news/nuwe-sec-filing-720010
View on StockTwits ↗$NUWE I loaded as much as I could today at 1.28 but I will add more a as soon as I sell other positions. This is setting up for a nice short squeeze . Earnings were not bad, COB is very high and short interest one of the highest in the market not mention the stock is extremely oversold.
View on StockTwits ↗$NUWE Buyers are finally are showing up or shorts are thinking it is time to covers some shares. Get ready for it.
View on StockTwits ↗$NUWE Added at 1.28. Negative over-reaction to earnings report. Over all AI sentiment - positive https://www.stocktitan.net/news/NUWE/nuwellis-reports-second-quarter-2026-financial-results-and-business-cf2rwtw5duon.html
View on StockTwits ↗$NUWE under $ soon. One of the biggest scams on the Nasdaq.
View on StockTwits ↗$NUWE still hoping this squeezes for you folks to get your money back.
View on StockTwits ↗$NUWE I am buying it for at 1.28 for the next short squeeze. Earnings were not that bad despite of the losses everything has improved. It can go lower but this is setting up for another short squeeze so i do not mind if it goes even lower at 1.10s in the next few days so I can add more.
View on StockTwits ↗$NUWE always trade with a Stop Loss. Was up 2k on this. Then went all in with 18k shares. Lost all my gains and an additional 3k. Capital was tied up for 1week. Sold for the rest yesterday and went straight to OFAL. Made 2k there yesterday. Hard to to these buy and hold and wait for a SS when the SI data isn’t being reported. You can tell the company is also doing ATM dilution.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $10M | +21.0% | $-80.15 | $-80.15–$-80.15 | — | 1 |
| 2027 | $11M | +12.0% | $-22.05 | $-22.05–$-22.05 | — | 1 |
| 2028 | $36M | +224.7% | $1043.70 | $1043.70–$1043.70 | 0.0× | 1 |
| 2029 | $49M | +37.8% | $2087.40 | $2087.40–$2087.40 | 0.0× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-13 | $-23.80 | $-26.64 | -11.9% |
| 2026-05-12 | $-0.35 | $-0.73 | -109.0% |
| 2026-03-10 | $-54.60 | $-1.50 | +97.3% |
| 2025-11-12 | $-17.22 | $0.56 | +103.3% |
| 2025-08-14 | $-0.19 | $-0.61 | -222.7% |
| 2025-05-13 | $-15.75 | $-28.98 | -84.0% |
| 2025-03-11 | $-18.06 | $-15.40 | +14.7% |
| 2024-11-11 | $-0.45 |
| $0.61 |
| +235.9% |
| $2M |
| — |
| NUVOHoldco Nuvo Group D.G Ltd. Ordinary Shares | $0.17 | +100.00% | $6M | — |
| OCEAOcean Biomedical, Inc. | $0.00 | +300.00% | $474541 | — |
Source: Financial Modeling Prep · peers by sector/industry